Bio Innovation Conference | Speakers
Presented by Maryland Life Sciences, a division of the Maryland Tech Council, the Bio Innovation Conference is driving the future of life sciences in Maryland. This conference provides a forum for professionals from industry, academia and government to discuss trends and insight into Maryland’s burgeoning life sciences industry and topics related to funding, structuring, commercialization and government relations.
Maryland Life Sciences Bio Innovation Conference, Bio Innovation Conference, Maryland, life sciences, biotechnology, Maryland Tech Council, bio, innovation, conference, Maryland Life Sciences, Bio Innovation Conference, vaccines, gene therapy, networking, Washington DC, DMV, Biohealth, biohealth capital region, sciences, entrepreneurship, entrepreneur, startup, Maryland Life Sciences Bio Innovation Conference, Maryland Tech Council Conference, annual conference
page-template,page-template-full_width,page-template-full_width-php,page,page-id-20088,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive


David Anderson
Quality Site Head

Michael Anderson, M.D
Senior Advisor, Children’s National Hospital, Senior Advisor to the Assistant Secretary for Preparedness and Response (ASPR), HHS

Erich Blatter, Ph.D.
Director, Process Science
Laboratory – MSAT

Matt Brady, Principal
Executive Vice President, Scheer Partners

Audrey Chang, Ph.D.
Executive Director, WuXiApptec

Abhishek Dhawan
Executive – Life Sciences

Lisa Dunkle, MD
Vice President, Global Medical Leader, Novavax, Inc.

Bill Enright
Chief Executive Officer

Allison Foss
Executive Director, Myasthenia Gravis Association

Michael Grace, Ph.D.
CMC Business Unit Lead, Biologics Consulting

Patrick Hanley
Chief and Director, Cellular Therapy Program, Children’s National Hospital

Jennifer Helfer, Ph.D.
Senior Director, Patient Advocacy & Engagement, Viridian Therapeutics, Inc.

Christopher Jewel, Ph.D.
Chief Scientific Officer, Cartesian Therapeutics

Ken Krisko
Partner, Cooley, LLP

Metin Kurtoglu, Ph.D.Chief Operating Officer, Cartesian Therapeutics

Pat Larrabee
President & CEO, Facility Logix

Heather Lombardi, Ph.D.
Director, Office of Cellular Therapy and Human Tissue, FDA/CEBER

Peter Marks, M.D., Ph.D.
Director of the Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA)

Tristan Marshall
Vice President, Process Development, REGENXBIO

Tammy McCracken, MS
Vice President, CMC Emerging therapies, ProPharma

Travis McCready
Head of Life Sciences, Industries America, JLL, Former President and CEO of Massachusetts Life Sciences Center

Sarah Meeks, Ph.D.
Senior Vice President, Global Business Development

Matthew Miessau
Senior Associate, Epidarex Capital

Sanat Mohanty, Ph.D.
Founder and CEO, Pienomial, Inc.

Sanjay Phogat, Ph.D.
Vice President, R&D, GSK

Martin Rosendale
Chief Executive Officer
Selnova, LLC

Gregory A. Sahagian, MD
CEO, The Neurology Center of Southern California

Kelly Schulz
Chief Executive Officer
Maryland Life Sciences

Patti Seymour
Managing Director, BPTG, BDO

Vivien Sheehan, MD, Ph.D.
Associate Professor of Pediatrics, Emory University School of Medicine

Mike Snodgrass
Senior AI Analyst

Brian Stamper
Executive Director of Manufacturing Sciences, AstraZeneca

Brad Stewart
MTC Board Chair, Senior Vice President, Business Development, Montgomery County Economic Development Corporation

Tonya Villafana, Ph.D
MPH, Global Franchise Head, Infection- Late V&I, AstraZeneca

Steven Walker
Chair, MDLS, Head of Global Marketing – Early Commercial & Portfolio Strategy, GSK

Aubrey Watkins, III
Senior Director, Corporate Development, Emergent Biosolutions

Chenghong Wei, Ph.D.
Director, CMC Regulatory Affairs, Astrazeneca

Hugh Welles, Ph.D.
Director of Synthetic Immunotherapy Development, Vaccitech

Daozhan Yu, Ph.D.
President and Chief Executive Officer, AAVnerGene, Inc.